Pacifichealth Laboratories Stock Total Debt
| PHLIDelisted Stock | USD 0.0001 0.00 0.00% |
PacificHealth Laboratories fundamentals help investors to digest information that contributes to PacificHealth Laboratories' financial success or failures. It also enables traders to predict the movement of PacificHealth Pink Sheet. The fundamental analysis module provides a way to measure PacificHealth Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PacificHealth Laboratories pink sheet.
PacificHealth |
PacificHealth Laboratories Company Total Debt Analysis
PacificHealth Laboratories' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current PacificHealth Laboratories Total Debt | 54.86 K |
Most of PacificHealth Laboratories' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PacificHealth Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
CompetitionBased on the latest financial disclosure, PacificHealth Laboratories has a Total Debt of 54.86 K. This is 100.0% lower than that of the Personal Products sector and 100.0% lower than that of the Consumer Staples industry. The total debt for all United States stocks is 100.0% higher than that of the company.
PacificHealth Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PacificHealth Laboratories' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of PacificHealth Laboratories could also be used in its relative valuation, which is a method of valuing PacificHealth Laboratories by comparing valuation metrics of similar companies.PacificHealth Laboratories is currently under evaluation in total debt category among its peers.
PacificHealth Fundamentals
| Return On Equity | -0.75 | ||||
| Return On Asset | -0.25 | ||||
| Profit Margin | (0.14) % | ||||
| Operating Margin | (0.14) % | ||||
| Current Valuation | 571.89 K | ||||
| Shares Outstanding | 20.87 M | ||||
| Price To Earning | (0.34) X | ||||
| Price To Book | 0.71 X | ||||
| Price To Sales | 0.07 X | ||||
| Revenue | 6.91 M | ||||
| Gross Profit | 2.99 M | ||||
| EBITDA | (861.23 K) | ||||
| Net Income | (486.31 K) | ||||
| Cash And Equivalents | 324.48 K | ||||
| Cash Per Share | 0.02 X | ||||
| Total Debt | 54.86 K | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 1.58 X | ||||
| Book Value Per Share | 0.04 X | ||||
| Cash Flow From Operations | (503.96 K) | ||||
| Earnings Per Share | (0.04) X | ||||
| Target Price | 2.8 | ||||
| Beta | -275.06 | ||||
| Market Capitalization | 87 | ||||
| Total Asset | 1.89 M | ||||
| Retained Earnings | (20.59 M) | ||||
| Working Capital | 676 K | ||||
| Current Asset | 1.84 M | ||||
| Current Liabilities | 1.17 M | ||||
| Z Score | -11.0 | ||||
| Net Asset | 1.89 M |
About PacificHealth Laboratories Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PacificHealth Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PacificHealth Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PacificHealth Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in PacificHealth Pink Sheet
If you are still planning to invest in PacificHealth Laboratories check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PacificHealth Laboratories' history and understand the potential risks before investing.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |